Kirt Phipps, Senior Manager 2, Toxicology and Regulatory Affairs, Food & Nutrition Group
Kirt Phipps is responsible for the placement and monitoring of toxicology studies at Intertek Health Sciences, including selection of an appropriate CRO, study design and dose level selection, overseeing in-life phases and critical review of draft reports. This is an essential component of the risk assessment for substances to be added to foods.
Kirt has authored numerous peer-reviewed scientific publications and confidential risk assessments for multiple ingredients and is involved in the preparation and submission of applications for regulated products (novel foods, food additives and food enzymes) in the European Union (EU). He has been responsible for resolving complex regulatory and toxicological queries raised by the European Commission and the European Food Safety Authority (EFSA), which has led to the ultimate approval of numerous applications.
In addition, Kirt has experience in the preparation of submissions for other global jurisdictions, such as for Generally Recognized as Safe (GRAS) status in the United States.
Publications written by Kirt Phipps:
- Oral administration of a novel hydrolyzed chicken sternal cartilage extract (BioCell Collagen®) reduces UVB-induced photoaging in mice, Phipps KR, Lee HY, Kim H, Jeon B (2020)
- Toxicological safety assessment of the human-identical milk oligosaccharide 3'-sialyllactose sodium salt, Phipps KR, Baldwin NJ, Lynch B, Stannard DR, Šoltésová A, Gilby B, Mikš MH, Röhrig CH (2019)
- Toxicological safety evaluation of the human‐identical milk oligosaccharide 6′‐sialyllactose sodium salt, Phipps KR, Baldwin NJ, Lynch B, Stannard DR, Šoltésová A, Gilby B, Mikš MH, Röhrig CH (2019)
- Toxicological safety evaluation of a novel highly bioavailable turmeric extract formulation, Phipps KR, Quesnot N, Privat K, Baldwin NJ, Ahlborn E, Fança‐Berthon P (2019)
- Preclinical safety evaluation of the human-identical milk oligosaccharide lacto-N-tetraose, Phipps KR, Baldwin N, Lynch B, Stannard DR, Šoltesová A, Gilby B, Mikš MH, Röhrig CH (2018)
- Safety evaluation of a mixture of the human-identical milk oligosaccharides 2'-fucosyllactose and difucosyllactose, Phipps KR, Baldwin N, Lynch B, Flaxmer J, Šoltesová A, Gilby B, Mikš MH, Röhrig CH (2018)
- Safety assessment of additives and ingredients for infants and young children, Baldwin N, Martyn D, Phipps KR (2017)
